Table 1:
Cohort Characteristics
| Pericardial fat volume | ||||
|---|---|---|---|---|
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | |
|
| ||||
| N | 758 | 758 | 758 | 758 |
| Pericardial fat volume, cm3 | 38.7 (31.8, 44.4) | 58.7 (54.1, 63.4) | 79.7 (73.8, 86.8) | 120.3 (105.5, 145.4) |
| Age, years | 54.0 (49.0, 61.0) | 56.5 (51.0, 64.0) | 58.0 (51.0, 66.0) | 59.0 (53.0, 66.0) |
| Female sex | 514 (67.8%) | 461 (60.8%) | 398 (52.5%) | 233 (30.7%) |
| Race/Ethnicity | ||||
| White | 296 (39.1%) | 275 (36.3%) | 288 (38.0%) | 348 (45.9%) |
| Asian | 83 (10.9%) | 129 (17.0%) | 130 (17.2%) | 65 (8.6%) |
| Black or African American | 274 (36.1%) | 215 (28.4%) | 156 (20.6%) | 116 (15.3%) |
| Hispanic | 105 (13.9%) | 139 (18.3%) | 184 (24.3%) | 229 (30.2%) |
| Body mass index, kg/m2 | 25.2 (4.3) | 27.2 (4.8) | 28.9 (5.0) | 31.6 (5.2) |
| Waist-hip ratio | 0.9 (0.1) | 0.9 (0.1) | 0.9 (0.1) | 1.0 (0.1) |
| Diabetes status | ||||
| Normal | 677 (89.3%) | 634 (83.6%) | 578 (76.3%) | 514 (67.8%) |
| Impaired fasting glucose | 43 (5.7%) | 76 (10.0%) | 104 (13.7%) | 144 (19.0%) |
| Diabetes (untreated) | 2 (0.3%) | 15 (2.0%) | 19 (2.5%) | 24 (3.2%) |
| Diabetes (treated) | 31 (4.1%) | 30 (4.0%) | 56 (7.4%) | 73 (9.6%) |
| Missing/unknown | 5 (0.7%) | 3 (0.4%) | 1 (0.1%) | 3 (0.4%) |
| Hypertension | 186 (24.5%) | 242 (31.9%) | 285 (37.6%) | 341 (45.0%) |
| Metabolic syndrome | 84 (11.1%) | 182 (24.0%) | 269 (35.5%) | 378 (49.9%) |
| FEV1, L | 2.20 (0.63) (n=740) | 2.15 (0.70) (n=739) | 2.16 (0.69) (n=729) | 2.27 (0.73) (n=726) |
| FVC, L | 3.00 (0.85) (n=740) | 2.94 (0.92) (n=738) | 2.92 (0.94) (n=729) | 3.11 (0.95) (n=726) |
| FEV1/FVC | 73.8 (8.1) (n=739) | 73.5 (8.9) (n=737) | 74.4 (8.5) (n=728) | 73.3 (8.9) (n=725) |
| Percent emphysema, % | 0.5 (0.1, 1.8) (n=758) | 0.5 (0.0, 2.0) (n=758) | 0.6 (0.1, 2.1) (n=758) | 0.6 (0.1, 2.2) (n=758) |
| Clinical events over follow-up period | ||||
| Atrial Fibrillation | 68 (9.0%) | 94 (12.4%) | 104 (13.7%) | 132 (17.4%) |
| Coronary Heart Disease | 16 (2.1%) | 23 (3.0%) | 24 (3.2%) | 37 (4.9%) |
| Congestive Heart Failure | 6 (0.8%) | 17 (2.2%) | 19 (2.5%) | 33 (4.4%) |